NSE filing, NSE: AKUMS. Summary written from the filing by ALFA Finder's alert engine.
Akums Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹722.70
- Market cap
- ₹11,375 Cr
- Revenue (annual)
- ₹4,359 Cr
- Net profit (annual)
- ₹255.2 Cr
- P/E (TTM)
- 39.0×Sector 46.1×
- Promoter holding
- 75.26%+0.00% QoQ
- FII holding
- 4.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akums Drugs & Pharmaceuticals Ltd
All →Akums Drugs & Pharmaceuticals Board Meeting Date
Akums Drugs intimated that its Board meeting is scheduled for 2 November 2026 to consider un-audited Q1 and H1 FY27 results. No financial figures or decisions have been announced yet.
Akums Drugs & Pharmaceuticals Legal & Regulatory
Akums Drugs and Pharmaceuticals received a ₹52.75 Crore NPPA demand notice. The company claims no liability, citing an indemnity agreement with its marketer.
- Value
- ₹52.75 Cr
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing notes the removal of two entities from the promoter group.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY2025-26 from NSE Sustainability Ratings & Analytics Limited. The rating was assigned voluntarily based on publicly available information.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has cancelled its participation in the Antique Healthcare Investor Conference scheduled for August 25, 2026, due to unavoidable medical reasons.
Akums Drugs & Pharmaceuticals Earnings Call Transcript: Key Takeaways
Akums reported strong Q1FY27 performance with 13.9% revenue growth and 56.1% PAT increase. Results were driven by a robust 18.6% growth in the CDMO segment and improved API pricing.
Other financial results announcements
All →Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY
Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹41.7 Cr · -12.4% YoY
MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr
MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹30.4 Cr
OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr
OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹10.5 Cr
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY
GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.4 Cr · +86.3% YoY
Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY
Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹429.4 Cr · +16.1% YoY